Literature DB >> 28148645

Nonlinear effects of hyperpolarizing shifts in activation of mutant Nav1.7 channels on resting membrane potential.

Mark Estacion1,2, Stephen G Waxman3,2.   

Abstract

The Nav1.7 sodium channel is preferentially expressed within dorsal root ganglion (DRG) and sympathetic ganglion neurons. Gain-of-function mutations that cause the painful disorder inherited erythromelalgia (IEM) shift channel activation in a hyperpolarizing direction. When expressed within DRG neurons, these mutations produce a depolarization of resting membrane potential (RMP). The biophysical basis for the depolarized RMP has to date not been established. To explore the effect on RMP of the shift in activation associated with a prototypical IEM mutation (L858H), we used dynamic-clamp models that represent graded shifts that fractionate the effect of the mutation on activation voltage dependence. Dynamic-clamp recording from DRG neurons using a before-and-after protocol for each cell made it possible, even in the presence of cell-to-cell variation in starting RMP, to assess the effects of these graded mutant models. Our results demonstrate a nonlinear, progressively larger effect on RMP as the shift in activation voltage dependence becomes more hyperpolarized. The observed differences in RMP were predicted by the "late" current of each mutant model. Since the depolarization of RMP imposed by IEM mutant channels is known, in itself, to produce hyperexcitability of DRG neurons, the development of pharmacological agents that normalize or partially normalize activation voltage dependence of IEM mutant channels merits further study.NEW & NOTEWORTHY Inherited erythromelalgia (IEM), the first human pain disorder linked to a sodium channel, is widely regarded as a genetic model of neuropathic pain. IEM is produced by Nav1.7 mutations that hyperpolarize activation. These mutations produce a depolarization of resting membrane potential (RMP) in dorsal root ganglion neurons. Using dynamic clamp to explore the effect on RMP of the shift in activation, we demonstrate a nonlinear effect on RMP as the shift in activation voltage dependence becomes more hyperpolarized.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  Nav1.7; dynamic clamp; persistent current

Mesh:

Substances:

Year:  2017        PMID: 28148645      PMCID: PMC5380781          DOI: 10.1152/jn.00898.2016

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  37 in total

Review 1.  The dynamic clamp comes of age.

Authors:  Astrid A Prinz; L F Abbott; Eve Marder
Journal:  Trends Neurosci       Date:  2004-04       Impact factor: 13.837

2.  Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H.

Authors:  Dmytro V Vasylyev; Chongyang Han; Peng Zhao; Sulayman Dib-Hajj; Stephen G Waxman
Journal:  J Neurophysiol       Date:  2014-01-08       Impact factor: 2.714

3.  The response of Na(V)1.3 sodium channels to ramp stimuli: multiple components and mechanisms.

Authors:  Mark Estacion; Stephen G Waxman
Journal:  J Neurophysiol       Date:  2012-10-31       Impact factor: 2.714

4.  Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy.

Authors:  Chongyang Han; Janneke G J Hoeijmakers; Shujun Liu; Monique M Gerrits; Rene H M te Morsche; Giuseppe Lauria; Sulayman D Dib-Hajj; Joost P H Drenth; Catharina G Faber; Ingemar S J Merkies; Stephen G Waxman
Journal:  Brain       Date:  2012-07-22       Impact factor: 13.501

5.  Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy.

Authors:  Theodore R Cummins; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

6.  Dynamic clamp: computer-generated conductances in real neurons.

Authors:  A A Sharp; M B O'Neil; L F Abbott; E Marder
Journal:  J Neurophysiol       Date:  1993-03       Impact factor: 2.714

7.  A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia.

Authors:  Tanya Z Fischer; Elaine S Gilmore; Mark Estacion; Emmanuella Eastman; Sean Taylor; Michel Melanson; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Ann Neurol       Date:  2009-06       Impact factor: 10.422

8.  Dynamic clamp with StdpC software.

Authors:  Ildikó Kemenes; Vincenzo Marra; Michael Crossley; Dávid Samu; Kevin Staras; György Kemenes; Thomas Nowotny
Journal:  Nat Protoc       Date:  2011-03-03       Impact factor: 13.491

9.  Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable.

Authors:  Sulayman D Dib-Hajj; Mark Estacion; Brian W Jarecki; Lynda Tyrrell; Tanya Z Fischer; Mark Lawden; Theodore R Cummins; Stephen G Waxman
Journal:  Mol Pain       Date:  2008-09-19       Impact factor: 3.395

10.  Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.

Authors:  R Cregg; J J Cox; D L H Bennett; J N Wood; R Werdehausen
Journal:  Br J Pharmacol       Date:  2014-08-29       Impact factor: 8.739

View more
  3 in total

1.  Fibroblast growth factor homologous factor 2 (FGF-13) associates with Nav1.7 in DRG neurons and alters its current properties in an isoform-dependent manner.

Authors:  Philip R Effraim; Jianying Huang; Angelika Lampert; Severine Stamboulian; Peng Zhao; Joel A Black; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Neurobiol Pain       Date:  2019-03-27

2.  Atypical changes in DRG neuron excitability and complex pain phenotype associated with a Nav1.7 mutation that massively hyperpolarizes activation.

Authors:  Jianying Huang; Malgorzata A Mis; Brian Tanaka; Talia Adi; Mark Estacion; Shujun Liu; Suellen Walker; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

3.  Using dynamic clamp to quantify pathological changes in the excitability of primary somatosensory neurons.

Authors:  Petri Takkala; Steven A Prescott
Journal:  J Physiol       Date:  2018-05-10       Impact factor: 5.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.